These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15749920)

  • 61. Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.
    Katsara M; Yuriev E; Ramsland PA; Tselios T; Deraos G; Lourbopoulos A; Grigoriadis N; Matsoukas J; Apostolopoulos V
    Immunology; 2009 Dec; 128(4):521-33. PubMed ID: 19930042
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood.
    Hofstetter HH; Kovalovsky A; Shive CL; Lehmann PV; Forsthuber TG
    J Neuroimmunol; 2007 Jul; 187(1-2):20-30. PubMed ID: 17482277
    [TBL] [Abstract][Full Text] [Related]  

  • 63. T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen.
    Benson JM; Campbell KA; Guan Z; Gienapp IE; Stuckman SS; Forsthuber T; Whitacre CC
    J Clin Invest; 2000 Oct; 106(8):1031-8. PubMed ID: 11032863
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
    Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK
    J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis.
    Wensky AK; Furtado GC; Marcondes MC; Chen S; Manfra D; Lira SA; Zagzag D; Lafaille JJ
    J Immunol; 2005 Feb; 174(3):1416-23. PubMed ID: 15661899
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis.
    Cua DJ; Groux H; Hinton DR; Stohlman SA; Coffman RL
    J Exp Med; 1999 Mar; 189(6):1005-10. PubMed ID: 10075984
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10.
    Huss DJ; Winger RC; Peng H; Yang Y; Racke MK; Lovett-Racke AE
    J Immunol; 2010 May; 184(10):5628-36. PubMed ID: 20393141
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells.
    Khoruts A; Miller SD; Jenkins MK
    J Immunol; 1995 Nov; 155(10):5011-7. PubMed ID: 7594508
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease.
    Lafaille JJ; Keere FV; Hsu AL; Baron JL; Haas W; Raine CS; Tonegawa S
    J Exp Med; 1997 Jul; 186(2):307-12. PubMed ID: 9221760
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats.
    Cautain B; Damoiseaux J; Bernard I; van Straaten H; van Breda Vriesman P; Boneu B; Druet P; Saoudi A
    Eur J Immunol; 2001 Apr; 31(4):1132-40. PubMed ID: 11298338
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.
    Natarajan C; Muthian G; Barak Y; Evans RM; Bright JJ
    J Immunol; 2003 Dec; 171(11):5743-50. PubMed ID: 14634082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
    J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis.
    Deng C; Minguela A; Hussain RZ; Lovett-Racke AE; Radu C; Ward ES; Racke MK
    J Immunol; 2002 May; 168(9):4511-8. PubMed ID: 11970996
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
    Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
    Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Massive production of Th2 cytokines by human CD4+ effector T cells transiently expressing the natural killer cell marker CD57/HNK1.
    Brinkmann V; Kristofic C
    Immunology; 1997 Aug; 91(4):541-7. PubMed ID: 9378492
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
    Natarajan C; Bright JJ
    J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
    Bedoui S; Miyake S; Lin Y; Miyamoto K; Oki S; Kawamura N; Beck-Sickinger A; von Hörsten S; Yamamura T
    J Immunol; 2003 Oct; 171(7):3451-8. PubMed ID: 14500640
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dihydropyridine receptors are selective markers of Th2 cells and can be targeted to prevent Th2-dependent immunopathological disorders.
    Savignac M; Gomes B; Gallard A; Narbonnet S; Moreau M; Leclerc C; Paulet P; Mariamé B; Druet P; Saoudi A; Fournié GJ; Guéry JC; Pelletier L
    J Immunol; 2004 May; 172(9):5206-12. PubMed ID: 15100258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.